Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$4.17M Sell
281,800
-888
-0.3% -$14K ﹤0.01% 2205
2014
Q2
$4.29M Sell
282,688
-28,427
-9% -$422K ﹤0.01% 2099
2014
Q1
$5.24M Sell
311,115
-14,202
-4% -$232K ﹤0.01% 1820
2013
Q4
$5.58M Sell
325,317
-6,651
-2% -$116K 0.01% 1763
2013
Q3
$5.04M Sell
331,968
-50,724
-13% -$725K 0.01% 1693
2013
Q2
$5.32M Buy
+382,692
New +$5.05M 0.01% 1559

Other funds holding NEOG

UBS's NEOG Position: Q3 2014 in Review

UBS reduced its Neogen (NEOG) stake by 0.31% in Q3 2014, selling an estimated $14K and leaving 281,800 shares worth $4.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2205.

UBS first reported a position in NEOG in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.58M in Q4 2013. 188 funds tracked by Wall St. Rank hold NEOG as of Q3 2014.

  • UBS held 281,800 shares of Neogen worth $4.17M as of Q3 2014.
  • UBS sold 888 Neogen shares in Q3 2014, an estimated $14K.
  • Neogen made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2205 holding.
  • UBS first reported a position in Neogen in Q2 2013 and has held it in 6 quarters since.
  • UBS's Neogen position peaked at $5.58M in Q4 2013.
  • 188 funds tracked by Wall St. Rank held Neogen as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.